Raymond James & Associates Spdr Ser Tr Spdr S&P Biotech E Transaction History
Raymond James & Associates
- $161 Billion
- Q3 2024
A detailed history of Raymond James & Associates transactions in Spdr Ser Tr Spdr S&P Biotech E stock. As of the latest transaction made, Raymond James & Associates holds 383,355 shares of XBI stock, worth $33.7 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
383,355
Previous 355,844
7.73%
Holding current value
$33.7 Million
Previous $33 Million
14.81%
% of portfolio
0.02%
Previous 0.02%
Shares
30 transactions
Others Institutions Holding XBI
# of Institutions
914Shares Held
102MCall Options Held
27.4MPut Options Held
38.6M-
Citigroup Inc11.2MShares$979 Million0.62% of portfolio
-
Morgan Stanley New York, NY10.2MShares$893 Million0.07% of portfolio
-
Goldman Sachs Group Inc New York, NY9.56MShares$839 Million0.14% of portfolio
-
Bank Of America Corp Charlotte, NC8.52MShares$748 Million0.07% of portfolio
-
Jpmorgan Chase & CO New York, NY8.01MShares$703 Million0.06% of portfolio